NEWS
![](https://www.rarecells.com/wp-content/uploads/2021/12/Rarecells_SeriesA_Fundraising-300x179.png)
![Alessandra Decina](https://www.rarecells.com/wp-content/uploads/2019/09/Favicon-Rarecells-150x150.png)
Press release : Rarecells, Inc. announces successful Series A funding, reaching $13 Million raised to develop Liquid Biopsy Early Cancer Detection Tests
NEW YORK and PARIS, Dec. 9, 2021 — Rarecells, Inc., an innovative Liquid Biopsy
![](https://www.rarecells.com/wp-content/uploads/2021/11/RarecellsPR_Iset_Leukemia-300x178.jpg)
![Alessandra Decina](https://www.rarecells.com/wp-content/uploads/2019/09/Favicon-Rarecells-150x150.png)
Press release : Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of Acute Myeloid Leukemia (AML)
New York, November 9th, 2021 — Rarecells, Inc., a healthcare company in the field
![](https://www.rarecells.com/wp-content/uploads/2021/04/photo-article-300x251.jpeg)
![Alessandra Decina](https://www.rarecells.com/wp-content/uploads/2019/09/Favicon-Rarecells-150x150.png)
Prof. Patrizia Paterlini-Brechot – Rarecells, Inc. – embarks on the search for the First Cell to beat cancer
We are delighted to join the prestigious The Oncology Think Tank, initiated by Prof. Azra
Press release : ISET® technology makes Circulating Tumor Cells accessible to target PDAC mutant genes detection in pancreatic cancer with an accuracy demonstrated by a targeted scNGS
PARIS, April 6, 2021 /PRNewswire/ — Rarecells Inc., a leading Liquid Biopsy company is pleased to
Press release : ISET® test results show substantial improvement in early detection of prostate cancer by identifying PSA-positive Circulating Tumor Cells
We are enthusiastic to share the results of the Professor Karin Ried and researchers of
![](https://www.rarecells.com/wp-content/uploads/2020/10/liqbio.jpeg-300x55.png)
![Alessandra Decina](https://www.rarecells.com/wp-content/uploads/2019/09/Favicon-Rarecells-150x150.png)
2nd Liquid Biopsies Congress – Global Exchange
Attend the Keynote presentation ”New non-invasive approaches for early diagnosis and follow up of
Press release : ISET® technology applied to DLA products from NSCLC patients identified more CTC than other systems
We are enthusiastic to share the results of the research conducted by Dr Tamminga
![](https://www.rarecells.com/wp-content/uploads/2020/02/WERE-HIRING-300x169.png)
![Alessandra Decina](https://www.rarecells.com/wp-content/uploads/2019/09/Favicon-Rarecells-150x150.png)
We are hiring!
[OPPORTUNITY] – Rarecells is looking to hire a Research Lab Director! 🧬🦠🔬 For more
![](https://www.rarecells.com/wp-content/uploads/2019/10/EXLBPEU2019-920x270-Web-Banner-300x88.png)
![Alessandra Decina](https://www.rarecells.com/wp-content/uploads/2019/09/Favicon-Rarecells-150x150.png)
Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference
Attend the Keynote presentation ” Clinical Applications of Circulating Tumor Cells in Predictive Oncology